Drug Shortage Report for MORPHINE SULFATE INJECTION EPIDURAL
Report ID | 197750 |
Drug Identification Number | 02498278 |
Brand name | MORPHINE SULFATE INJECTION EPIDURAL |
Common or Proper name | MORPHINE SULFATE INJECTION EPIDURAL |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | MORPHINE SULFATE |
Strength(s) | 0.5MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL |
Packaging size | 10 X 10 ML VIALS |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-07-07 |
Estimated end date | 2023-07-31 |
Actual end date | 2023-07-28 |
Shortage status | Resolved |
Updated date | 2023-07-29 |
Company comments | Limited inventory remains at McKesson. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-07-29 | English | Compare |
v7 | 2023-07-28 | French | Compare |
v6 | 2023-07-28 | English | Compare |
v5 | 2023-07-21 | French | Compare |
v4 | 2023-07-21 | English | Compare |
v3 | 2023-07-08 | English | Compare |
v2 | 2023-07-06 | French | Compare |
v1 | 2023-07-06 | English | Compare |
Showing 1 to 8 of 8